ANXA5 and glioblastoma: Annexin V staining revealed that the number of surviving CD44‐positive GBM‐MG1 and GBM‐MG2 cells was significantly higher than that of CD44‐negative GBM‐MG1 and GBM‐MG2 cells (Figure 3I).